These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31748894)

  • 21. In vivo bioactivity of rhBMP-2 delivered with novel polyelectrolyte complexation shells assembled on an alginate microbead core template.
    Abbah SA; Liu J; Lam RW; Goh JC; Wong HK
    J Control Release; 2012 Sep; 162(2):364-72. PubMed ID: 22846985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuning the bioactivity of bone morphogenetic protein-2 with surface immobilization strategies.
    Chen R; Yu Y; Zhang W; Pan Y; Wang J; Xiao Y; Liu C
    Acta Biomater; 2018 Oct; 80():108-120. PubMed ID: 30218780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discontinuous and continuous separation of the monomeric and dimeric forms of human bone morphogenetic protein-2 from renaturation batches.
    Gueorguieva L; Vallejo LF; Rinas U; Seidel-Morgenstern A
    J Chromatogr A; 2006 Dec; 1135(2):142-50. PubMed ID: 17064713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo.
    Boyan BD; Lohmann CH; Somers A; Niederauer GG; Wozney JM; Dean DD; Carnes DL; Schwartz Z
    J Biomed Mater Res; 1999 Jul; 46(1):51-9. PubMed ID: 10357135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ectopic osteogenesis effect of antigen-extracted xenogeneic cancellous bone graft with chitosan/rhBMP-2/bFGF sequential sustained-release nanocapsules.
    Li ZJ; Lu CT; Lai RF
    J Biomater Appl; 2018 Jul; 33(1):23-43. PubMed ID: 29498305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of recombinant human BMP-6 in Escherichia coli and its purification and bioassay in vitro].
    Yang JH; Zhao L; Yang S; Wu SQ; Zhang J; Zhu TH
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):556-60. PubMed ID: 15969083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems.
    Schrier JA; DeLuca PP
    Pharm Dev Technol; 1999; 4(4):611-21. PubMed ID: 10578516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimizing the severity of rhBMP-2-induced inflammation and heterotopic ossification with a polyelectrolyte carrier incorporating heparin on microbead templates.
    Wang M; Abbah SA; Hu T; Toh SY; Lam RW; Goh JC; Wong HK
    Spine (Phila Pa 1976); 2013 Aug; 38(17):1452-8. PubMed ID: 23380826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryogenic 3D printing for producing hierarchical porous and rhBMP-2-loaded Ca-P/PLLA nanocomposite scaffolds for bone tissue engineering.
    Wang C; Zhao Q; Wang M
    Biofabrication; 2017 Jun; 9(2):025031. PubMed ID: 28589918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface mineralization of Ti6Al4V substrates with calcium apatites for the retention and local delivery of recombinant human bone morphogenetic protein-2.
    Liu P; Smits J; Ayers DC; Song J
    Acta Biomater; 2011 Sep; 7(9):3488-95. PubMed ID: 21651998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Codon optimization for high level expression of human bone morphogenetic protein-2 in Escherichia coli.
    Retnoningrum DS; Pramesti HT; Santika PY; Valerius O; Asjarie S; Suciati T
    Protein Expr Purif; 2012 Aug; 84(2):188-94. PubMed ID: 22691543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polysaccharide-blend multilayers containing hyaluronan and heparin as a delivery system for rhBMP-2.
    Crouzier T; Szarpak A; Boudou T; Auzély-Velty R; Picart C
    Small; 2010 Mar; 6(5):651-62. PubMed ID: 20155753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites.
    Ruhe PQ; Hedberg EL; Padron NT; Spauwen PH; Jansen JA; Mikos AG
    J Bone Joint Surg Am; 2003; 85-A Suppl 3():75-81. PubMed ID: 12925613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization and promotion of recombinant human bone morphogenetic protein-2 bioactivity on extracellular matrix mimetic chondroitin sulfate-functionalized calcium phosphate cement scaffolds.
    Huang B; Wu Z; Ding S; Yuan Y; Liu C
    Acta Biomater; 2018 Apr; 71():184-199. PubMed ID: 29355717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of bone morphogenetic protein and proportion of hydroxyapatite on new bone formation in biphasic calcium phosphate graft: two pilot studies in animal bony defect model.
    Yun PY; Kim YK; Jeong KI; Park JC; Choi YJ
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1909-17. PubMed ID: 25443868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone induction by Escherichia coli -derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2.
    Bessho K; Konishi Y; Kaihara S; Fujimura K; Okubo Y; Iizuka T
    Br J Oral Maxillofac Surg; 2000 Dec; 38(6):645-649. PubMed ID: 11092786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2).
    Kato M; Toyoda H; Namikawa T; Hoshino M; Terai H; Miyamoto S; Takaoka K
    Biomaterials; 2006 Mar; 27(9):2035-41. PubMed ID: 16256191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosilicate nanocomposite: a novel resorbable bioactive tissue engineering scaffold for BMP and bone-marrow cell delivery.
    El-Ghannam A; Ning CQ; Mehta J
    J Biomed Mater Res A; 2004 Dec; 71(3):377-90. PubMed ID: 15470721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation.
    Luca L; Rougemont AL; Walpoth BH; Gurny R; Jordan O
    J Control Release; 2010 Oct; 147(1):38-44. PubMed ID: 20600403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of hydrolyzable polyethylene glycol hydrogels and deproteinized bone mineral as delivery systems for glycosylated and non-glycosylated bone morphogenetic protein-2.
    Hänseler P; Jung UW; Jung RE; Choi KH; Cho KS; Hämmerle CH; Weber FE
    Acta Biomater; 2012 Jan; 8(1):116-23. PubMed ID: 21867781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.